All 142 XBI Holdings

XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. XBI is suitable for investors seeking to capitalize on the growth potential and innovation within the biotechnology industry. Due to the sector's inherent volatility, XBI might experience significant price swings and is considered a higher-risk investment compared to broader market funds.